Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Adams and Jason Van Tassel

Premium

Thomas Adams has joined the board of directors of Xenomics, the New York-based company said yesterday. He was a founder of Genta. He is also CEO of Leucadia Technologies, and was co-founder, chairman, and CEO of Gen Probe.


Jason Van Tassel was named to the scientific advisory board of CalbaTech, which owns antisense and RNAi reagent firm Molecula. Van Tassel is a physician with a practice specializing in plastic surgery in Los Angeles. Previously, he was a researcher with Hybritech. CalbaTech is an early-stage company focusing on the acquisition of molecular and cellular biology technology platforms in the US and the UK.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.